France· FR:64087306

HYDROXYCARBAMIDE ARROW 500 mg, gélule

A hydroxycarbamide product containing hydroxycarbamide, registered in France by EUGIA PHARMA (MALTA) (MALTE). The same ATC class is registered in 16 of our 19 countries.

ATC L01XX05

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about hydroxycarbamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxycarbamide is registered in 16 of 19 countries.

Countries holding a registration under ATC L01XX05 (hydroxycarbamide), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
10 of them publish a price we can compare per daily dose

Search hydroxycarbamide products by name

Hydroxycarbamide · ATC L01XX05

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of hydroxycarbamide costs, country by country.

Normalised to the WHO defined daily dose (1.4 g), the median price runs from $0.51 in United States to $16.83 in France — a ×33 gap.

France: $16.83 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Hydroxycarbamide · price per daily dose (1.4 g)

USD · FX 28 Sept 2026

FR France$16.83
CH Switzerland$2.74
IT Italy$1.13
US United States$0.51 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: HYDROXYCARBAMIDE
Manufacturer: EUGIA PHARMA (MALTA) (MALTE)
Country: France (FR)
ATC code: L01XX05
ATC class: Hydroxycarbamide
Defined daily dose: 1.4 g, O
Reimbursed: No
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

cip13
3400930292129
plaquette(s) PVC PVDC aluminium de 20 gÃ©lules

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

333 interactions on record for hydroxycarbamide.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check hydroxycarbamide against other medicines How interaction checks work

Hydroxycarbamide · interactions on record

333 records

31 severe
101 moderate
15 minor
186 info

Most severe, free to view

DidanosineJ05AF02severe
CladribineL01BB04severe
Talimogene laherparepvecL01XL02severe
Talimogen laherparepvecL01XX51severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxycarbamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxycarbamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Ardjaq, Hydroxycarbamid Devatis
Belgium · Hydrea
Bulgaria · Хидреа
Cyprus · Hydreasyn
Czechia · Litalir
Germany · Ardjaq, Hydroxycarbamid 1 A Pharma
Denmark · Hydroxyurea Medac, Oribamide
Estonia · Hydrea
Spain · Hidroxicarbamida Hikma, Hidroxicarbamida Medac
Finland · Hydrea, Hydroxyurea Medac
United Kingdom (Northern Ireland) · Hydrea, Hydroxycarbamide
Greece · Hydreasyn
Croatia · Litalir, Xybaid
Hungary · Hydroxycarbamide Pharmacenter, Litalir
Ireland · Hydrea
Iceland · Hydroxyurea Medac, Siklos
Italy · Idrossicarbamide Aurobindo, Onco Carbide
Liechtenstein · Siklos
Lithuania · Hydrea
Luxembourg · Hydrea, Hydroxycarbamid Devatis
Latvia · Hydrea
Malta · Hydroxycarbamide Eugia
Netherlands · Hydroxycarbamide Devatis, Hydroxycarbamide Eugia
Norway · Hydroxyurea Medac, Oribamide
Poland · Hydroxycarbamid Eugia, Hydroxycarbamid Teva
Portugal · Hidroxicarbamida Generis, Hidroxicarbamida Hikma
Romania · Hydrea
Sweden · Hydrea, Hydroxyurea Medac
Slovenia · Hidroksisečnina Aptapharma, Litalir
Slovakia · Hydroxykarbamid Medac, Xybaid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/96fffcda-8955-4f37-811a-381cef8bacae
GET /v1/drugs/96fffcda-8955-4f37-811a-381cef8bacae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64087306",
  "date_amm": "2024-03-14",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "HYDROXYCARBAMIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about hydroxycarbamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console